Should You Buy The Dogs Of The FTSE For 2015? Royal Dutch Shell Plc, GlaxoSmithKline plc, Standard Chartered PLC, Direct Line Insurance Group PLC And Admiral Group plc

Royal Dutch Shell Plc (LON:RDSB), GlaxoSmithKline plc (LON:GSK), Standard Chartered PLC (LON:STAN), Direct Line Insurance Group PLC (LON:DLG) and Admiral Group plc (LON:ADM) could all beat the market in 2015.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

This is the second part of my two-part series looking at the 10 FTSE 100 stocks that qualify for a UK version of the popular Dogs of the Dow high-yield investment strategy.

The Dogs strategy involves buying the 10 highest-yielding stocks in the index at the start of the year, and then selling them at the end of the year. In the US, the Dogs strategy has beaten the Dow in two of the last three years.

Here are the final five 2015 Dog stocks from the FTSE 100 (if you missed the first five stocks, you can catch up here):

Company

2015 prospective yield

Royal Dutch Shell (LSE: RDSB)

5.9%

GlaxoSmithKline (LSE: GSK)

5.9%

Standard Chartered (LSE: STAN)

6.0%

Direct Line Insurance Group (LSE: DLG)

7.4%

Admiral Group (LSE: ADM)

6.9%

Shell

No-one quite knows how the oil market will behave next year.

However, Shell should be able to afford to ride out the storm, thanks to its huge scale, large gas business and low debt levels.

Although cash flow could come under pressure next year, the firm’s forecast P/E of 9.8 suggests to me that Shell remains a safe income buy.

GlaxoSmithKline

Allegations of bribery and corruption, patent expiries, and falling profits.

It’s been a poor year for Glaxo, but this has left the UK’s largest pharmaceutical firm trading with a prospective yield of nearly 6% and a planned 82p per share capital return in 2015.

Glaxo remains in my portfolio, and on my buy list.

Standard Chartered

Shares in Asia-focused Standard Chartered have fallen by around 35% this year, amid a constant run of downgraded forecasts.

As a result, the bank’s shares trade on a 2015 forecast P/E of just 8.1, which prices in a lot of bad news, in my view. A prospective yield of around 5.9% should also reward patient investors.

Direct Line

Direct Line makes it into the Dogs of the FTSE thanks to a generous special dividend policy, which gives the firm’s shares a prospective yield of 7.4%, the highest in this group.

The fall in motor insurance premiums does seem to be slowing, so 2015 could be a reasonable year for Direct Line.

Admiral

As with Direct Line, it’s important to remember that these insurers’ generous yields are driven by special dividends, which are currently being paid every year, but may not be in the future.

That aside, Admiral’s 2015 forecast P/E of 14.2 reflects the fact that earnings per share are expected to fall by around 8% next year, raising the risk that dividend growth could also stall.

Roland Head owns shares in Royal Dutch Shell and GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

5 years ago £10k bought 4,484 Tesco shares. How many would it buy today?

Harvey Jones is astonished by how well Tesco shares have done lately. Can the FTSE 100 stock continue its strong…

Read more »

View of the Birmingham skyline including the church of St Martin, the Bullring shopping centre and the outdoor market.
Investing Articles

3,703 Legal & General shares pay £822 yearly passive income

Legal & General shares are a popular option for those looking to create passive income. But why are so many…

Read more »

Rolls-Royce engineer working on an engine
Investing Articles

5 years ago, £10,000 bought 9,827 Rolls-Royce shares. But how many would it buy now?

Without doubt, Rolls-Royce shares have been one of the UK's top success stories in the past five years. But what…

Read more »

Rear view image depicting two men hiking together with the stunning backdrop of Seven Sisters cliffs in the south of England.
Investing Articles

No savings at 30? How investing £5 a day in an ISA could target a stunning second income of £40,208 a year

At 30, investors still have the world at their feet. Harvey Jones shows how they can aim for a brilliant…

Read more »

Two elderly people relaxing in the summer sunshine Box Hill near Dorking Surrey England
Investing Articles

Here’s how much an investor needs in Lloyds shares to earn a £125 monthly income

Harvey Jones crunches the numbers to show how Lloyds' shares can deliver a high-and-rising regular income, with potential capital growth…

Read more »

Investing Articles

Down 45% in 5 years, this UK stock now offers a stunning 11% dividend yield!

Among the highest UK dividend yields, one immediately begs for closer inspection. Can this double-digit marvel really pull it off?

Read more »

Middle-aged black male working at home desk
Investing Articles

Here’s how Aviva shares could soon rise a further 20%… or fall 15%!

Aviva shares have fallen back a bit, with Q1 results due in May. But analysts are mostly optimistic, and see…

Read more »

Dominos delivery man on skateboard holding pizza boxes
Investing Articles

£5,000 invested in high-yield FTSE 250 stock Domino’s Pizza on 7 April is now worth…

Anyone who put £5,000 into FTSE stock Domino’s Pizza after the Easter break would now be laughing as its share…

Read more »